4/A
Changes in Ownership
AbbVie Inc. Filed Acc 0001415889-25-003337
EVP, R&D and CSO acquired 11,088 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thakkar Roopal EVP, R&D and CSO | 2024-02-15 | Grant or award | +5,900 | 36,125 | D | ||
| Thakkar Roopal EVP, R&D and CSO | 2024-02-15 | Grant or award | +1,572 | 37,697 | D | ||
| Thakkar Roopal EVP, R&D and CSO | 2024-02-15 | Grant or award | +1,476 | 39,173 | D | ||
| Thakkar Roopal EVP, R&D and CSO | 2024-02-15 | Grant or award | +2,140 | 41,313 | D | ||
| Derivatives | |||||||
| Thakkar Roopal EVP, R&D and CSO | 2024-02-15 | Grant or award · Option (Right to buy) | +13,868 | 13,868 | D | ||
Loading xslF345X05/form4a-02072025_040201.xml…